Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
![Insider Trading Transactions for Drugs Made In America Acquisition Corp.](/ichart-2028614-930-180-60.png)
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2025-01-29 Purchase | 2025-02-04 7:41 pm | Drugs Made In America Acquisition Corp. | DMAA | Drugs Made In America Acquisition LLC 10% Owner | 400,000 | $0 | $0 | 4,958,780 (Direct) | View |
2025-01-29 Sale | 2025-02-04 7:41 pm | Drugs Made In America Acquisition Corp. | DMAA | Drugs Made In America Acquisition LLC 10% Owner | 5,698,363 | $0 | $0 | 4,958,780 (Direct) | View |
2025-01-29 Purchase | 2025-02-04 7:40 pm | Drugs Made In America Acquisition Corp. | DMAA | Stockwell Lynn CEO and Executive COB 10% Owner | 400,000 | $0 | $0 | 4,958,780 (Indirect) | View |
2025-01-29 Sale | 2025-02-04 7:40 pm | Drugs Made In America Acquisition Corp. | DMAA | Stockwell Lynn CEO and Executive COB 10% Owner | 5,698,363 | $0 | $0 | 4,958,780 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-01-29 Other | 2025-02-04 7:41 pm | N/A N/A | Drugs Made In America Acquisition Corp. | DMAA | Drugs Made In America Acquisition LLC 10% Owner | 400,000 | $0 | 4,958,780 (Direct) | View |
2025-01-29 Other | 2025-02-04 7:40 pm | N/A N/A | Drugs Made In America Acquisition Corp. | DMAA | Stockwell Lynn CEO and Executive COB 10% Owner | 400,000 | $0 | 4,958,780 (Indirect) | View |
2025-01-29 Other | 2025-02-03 7:27 pm | N/A N/A | Drugs Made In America Acquisition Corp. | DMAA | Shulgan Myron W. Director | 100,000 | $0 | 200,000 (Direct) | View |
2025-01-29 Other | 2025-02-03 7:25 pm | N/A N/A | Drugs Made In America Acquisition Corp. | DMAA | Prasad Sridhar G. Director | 100,000 | $0 | 200,000 (Direct) | View |
2025-01-29 Other | 2025-02-03 7:23 pm | N/A N/A | Drugs Made In America Acquisition Corp. | DMAA | Do Catherine Director | 100,000 | $0 | 200,000 (Direct) | View |
2025-01-29 Other | 2025-02-03 7:21 pm | N/A N/A | Drugs Made In America Acquisition Corp. | DMAA | Worman Glenn C. CFO | 100,000 | $0 | 200,000 (Direct) | View |
Ownership | 2025-01-10 07:47 am | N/A N/A | Drugs Made In America Acquisition Corp. | DMAA | Drugs Made In America Acquisition LLC 10% Owner | 0 | $0 | 9,857,143 (Direct) | View |
Ownership | 2025-01-10 07:45 am | N/A N/A | Drugs Made In America Acquisition Corp. | DMAA | Stockwell Lynn See Remarks 10% Owner | 0 | $0 | 9,857,143 (Indirect) | View |